SCHEMBL1492769

SCHEMBL1492769

Cc1cc(-c2ccc(NC(=O)NCC3(c4cccc(Cl)n4)CCCC3)cc2)ccn1

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 13/20 0.46
PSEN2 P49810 13/20 0.46
APH1B Q8WW43 13/20 0.46
NCSTN Q92542 13/20 0.46
APH1A Q96BI3 13/20 0.46
PSENEN Q9NZ42 13/20 0.46
PORCN Q9H237 3/20 0.45
WNT3A P56704 2/20 0.45
ROCK2 O75116 1/20 0.41
MCHR1 Q99705 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492709 0.87 WNT3A (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492828 0.85 MAPK1 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492752 0.84 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492753 0.83 MAPK1 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492842 0.82 WNT3A (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1493069 0.81 MAPK1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492669 0.81 PSEN1 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492774 0.81 WNT3A (0.54) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1492808 0.78 CNR1 (0.59) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL27809668 0.77 ROCK2 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP disclosed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO disclosed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 PSEN1 3/4885PSEN2 4/4885APH1B 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.